Dr. Leona Gilbert is a Docent in Cell and Molecular Biology and the CEO of Te?ted Oy, a pioneering university spinoff company focused on enabling faster, more accurate diagnoses to support timely treatment and recovery for patients. With a Ph.D. in biotechnology, Dr. Gilbert brings extensive experience in bio-innovation and bio-business, bridging the gap between academic research and clinical application. Over the years, she has mentored numerous PhD, MSc, and BSc students, fostering a new generation of scientists.

Her extensive portfolio of peer-reviewed publications reflects a strong translational focus—developing cutting-edge delivery vectors and diagnostic platforms from foundational research. A significant body of her work investigates the role of common viruses and bacteria in triggering autoimmune diseases, offering insights into the complex interplay between infection and chronic illness. Dr. Gilbert’s research is deeply interdisciplinary, showcasing collaborations among patients, clinicians, microbiologists, diagnostic
developers, nanoscientists, physicists, and engineers. Her recent initiatives concentrate on comprehensive diagnostic platforms and patient profiling in the context of tick-borne and autoimmune diseases, advancing our understanding of how chronic conditions
may emerge from persistent infections.